J3380 Injection vedolizumab intravenous 1 milligrams
J-Codes
Also known as: vedolizumab, Entyvio, integrin inhibitor
Vedolizumab intravenous 1 milligram injection is a monoclonal antibody targeting alpha-4-beta-7 integrin for inflammatory bowel disease treatment.
Clinical Context
Indicated for moderate to severe Crohn's disease and ulcerative colitis. Blocks alpha-4-beta-7 integrin adhesion molecule to reduce intestinal inflammation. Administered intravenously with induction and maintenance dosing.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.